SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Grand View Research | PRODUCT CODE: 2132589

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2132589

Ambulatory Infusion Centers Market Size, Share & Trends Analysis Report By Therapy Area (Oncology), By Ownership Model (Independent Centers), By Age Group, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 181 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Ambulatory Infusion Centers Market Summary

The global ambulatory infusion centers market size was estimated at USD 40.9 billion in 2025 and is projected to grow from USD 43.7 billion in 2026 to USD 76.2 billion by 2033, growing at a CAGR of 8.3% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 36.8% in 2025. This growth is attributed to the increasing prevalence of chronic diseases, expanding use of specialty infusion therapies, and the shift toward cost-effective outpatient care. Moreover, favorable reimbursement policies, increasing investments in independent infusion centers, and growing patient preference for convenient, accessible, and personalized infusion services are further supporting market expansion.

The section below outlines the key factors driving the growth of the ambulatory infusion centers market, highlighting the rising prevalence of chronic diseases requiring long-term infusion therapies and the growing shift from hospital-based care to cost-effective outpatient settings. It also examines the increasing adoption of specialty biologics and injectable therapies, favorable reimbursement policies, expanding investments in independent infusion centers, and rising patient preference for convenient, accessible, and personalized infusion services.

Global Ambulatory Infusion Centers Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on industry trends in each of the segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the ambulatory infusion centers market report on the basis of therapy area, ownership model, age group and region:

  • Therapy Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Autoimmune & Inflammatory Disorders
  • Neurology
  • Infectious Diseases
  • Hematology
  • Immunodeficiency Disorders
  • Endocrine & Metabolic Disorders
  • Rare Diseases
  • Others
  • Ownership Model Outlook (Revenue, USD Million, 2021 - 2033)
  • Independent Centers
  • Hospital-Owned Centers
  • Physician-Owned Centers
  • Specialty Pharmacy-Owned Centers
  • Age Group Outlook (Revenue, USD Million, 2021 - 2033)
  • Pediatric
  • Adult
  • Geriatric
  • Regional Outlook (Revenue in USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • New Zealand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • Kuwait
    • UAE
Show more
Product Code: GVR-4-68041-016-0

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Therapy Area
    • 1.1.2. Ownership Model
    • 1.1.3. Age Group
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Therapy area outlook
    • 2.2.2. Ownership model outlook
    • 2.2.3. Age group outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Ambulatory Infusion Centers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising adoption of biologic and specialty drugs
      • 3.2.1.2. Growing shift from hospital-based infusion to cost-effective ambulatory care
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Shortage of skilled infusion nurses and healthcare professionals
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenge analysis
  • 3.3. Ambulatory Infusion Centers Market Analysis Tools
    • 3.3.1. Porter's five forces analysis
    • 3.3.2. PESTLE analysis

Chapter 4. Ambulatory Infusion Centers Market: Therapy Area Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Therapy Area Market Share, 2025 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Ambulatory Infusion Centers Market by Therapy Area Outlook
    • 4.4.1. Oncology
      • 4.4.1.1. Oncology Market estimates and forecast, 2021 to 2033 (USD Million)
    • 4.4.2. Autoimmune & Inflammatory Disorders
      • 4.4.2.1. Autoimmune & Inflammatory Disorders Market estimates and forecast, 2021 to 2033 (USD Million)
    • 4.4.3. Neurology
      • 4.4.3.1. Neurology Market estimates and forecast, 2021 to 2033 (USD Million)
    • 4.4.4. Infectious Diseases
      • 4.4.4.1. Infectious Diseases Market estimates and forecast, 2021 to 2033 (USD Million)
    • 4.4.5. Hematology
      • 4.4.5.1. Hematology Market estimates and forecast, 2021 to 2033 (USD Million)
    • 4.4.6. Immunodeficiency Disorders
      • 4.4.6.1. Immunodeficiency Disorders Market estimates and forecast, 2021 to 2033 (USD Million)
    • 4.4.7. Endocrine & Metabolic Disorders
      • 4.4.7.1. Endocrine & Metabolic Disorders Market estimates and forecast, 2021 to 2033 (USD Million)
    • 4.4.8. Rare Diseases
      • 4.4.8.1. Rare Diseases Market estimates and forecast, 2021 to 2033 (USD Million)
    • 4.4.9. Others
      • 4.4.9.1. Others Market estimates and forecast, 2021 to 2033 (USD Million)

Chapter 5. Ambulatory Infusion Centers Market: Ownership Model Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Ownership Model Market Share, 2025 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Ambulatory Infusion Centers Market by Ownership Model Outlook
    • 5.4.1. Independent Centers
      • 5.4.1.1. Independent Centers Market estimates and forecast, 2021 to 2033 (USD Million)
    • 5.4.2. Hospital-Owned Centers
      • 5.4.2.1. Hospital-Owned Centers Market estimates and forecast, 2021 to 2033 (USD Million)
    • 5.4.3. Physician-Owned Centers
      • 5.4.3.1. Physician-Owned Centers Market estimates and forecast, 2021 to 2033 (USD Million)
    • 5.4.4. Specialty Pharmacy-Owned Centers
      • 5.4.4.1. Specialty Pharmacy-Owned Centers Market estimates and forecast, 2021 to 2033 (USD Million)

Chapter 6. Ambulatory Infusion Centers Market: Age Group Estimates & Trend Analysis

  • 6.1. Definition and Scope
  • 6.2. Age Group Market Share, 2025 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Global Ambulatory Infusion Centers Market by Age Group Outlook
    • 6.4.1. Pediatric
      • 6.4.1.1. Pediatric Market estimates and forecast, 2021 to 2033 (USD Million)
    • 6.4.2. Adult
      • 6.4.2.1. Adult Market estimates and forecast, 2021 to 2033 (USD Million)
    • 6.4.3. Geriatric
      • 6.4.3.1. Geriatric Market estimates and forecast, 2021 to 2033 (USD Million)

Chapter 7. Ambulatory Infusion Centers Market: Regional Estimates & Trend Analysis, By Therapy Area, By Ownership Model, By Age Group

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. New Zealand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market position analysis, 2025
    • 8.3.1. Option Care Health, Inc.
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Service benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Coram CVS Specialty Infusion Services
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Service benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Amerita, Inc.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Service benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. KabaFusion
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Service benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. BioMatrix Specialty Pharmacy
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Service benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Paragon Healthcare, Inc.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Service benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Healix, Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Service benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Vivo Infusion
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Service benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Pure Infusion
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Service benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. AIS Healthcare
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Service benchmarking
      • 8.3.10.4. Strategic initiatives
Show more
Product Code: GVR-4-68041-016-0

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 4 North America ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 5 North America ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 6 U.S. ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 7 U.S. ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 8 Canada ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 9 Canada ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 10 Canada ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 11 Mexico ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 12 Mexico ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 13 Mexico ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 14 Europe ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 15 Europe ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 16 Europe ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 17 UK ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 18 UK ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 19 UK ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 20 Germany ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 21 Germany ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 22 Germany ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 23 France ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 24 France ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 25 France ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 26 Italy ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 27 Italy ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 28 Italy ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 29 Spain ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 30 Spain ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 31 Spain ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 32 Sweden ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 33 Sweden ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 34 Sweden ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 35 Denmark ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 36 Denmark ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 37 Denmark ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 38 Norway ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 39 Norway ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 40 Norway ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 41 Asia Pacific ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 42 Asia Pacific ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 43 Asia Pacific ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 44 Japan ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 45 Japan ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 46 Japan ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 47 China ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 48 China ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 49 China ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 50 India ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 51 India ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 52 India ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 53 Australia ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 54 Australia ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 55 Australia ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 56 South Korea ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 57 South Korea ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 58 South Korea ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 59 Thailand ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 60 Thailand ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 61 Thailand ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 62 Latin America ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 63 Latin America ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 64 Latin America ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 65 Brazil ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 66 Brazil ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 67 Brazil ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 68 Argentina ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 69 Argentina ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 70 Argentina ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 71 MEA ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 72 MEA ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 73 MEA ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 74 South Africa ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 75 South Africa ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 76 South Africa ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 77 Saudi Arabia ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 78 Saudi Arabia ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 79 Saudi Arabia ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 80 UAE ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 81 UAE ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 82 UAE ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)
  • Table 83 Kuwait ambulatory infusion centers market, by therapy area, 2021 - 2033 (USD Million)
  • Table 84 Kuwait ambulatory infusion centers market, by ownership model, 2021 - 2033 (USD Million)
  • Table 85 Kuwait ambulatory infusion centers market, by age group, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Ambulatory infusion centers market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Supply-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Market segmentation
  • Fig. 10 Market segmentation
  • Fig. 11 Competitive landscape
  • Fig. 12 Parent market outlook
  • Fig. 13 Ambulatory infusion centers market dynamics
  • Fig. 14 Ambulatory infusion centers market: Porter's five forces analysis
  • Fig. 15 Ambulatory infusion centers market: PESTLE analysis
  • Fig. 16 Ambulatory infusion centers market: Therapy area segment dashboard
  • Fig. 17 Ambulatory infusion centers market: Therapy area market share analysis, 2025 & 2033
  • Fig. 18 Oncology ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 19 Autoimmune & inflammatory disorders ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 20 Neurology ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 21 Infectious diseases ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 22 Hematology ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 23 Immunodeficiency disorders ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 24 Endocrine & metabolic disorders ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 25 Rare diseases ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 26 Others ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 27 Ambulatory infusion centers market: Ownership model segment dashboard
  • Fig. 28 Ambulatory infusion centers market: Ownership model market share analysis, 2025 & 2033
  • Fig. 29 Independent centers, market, 2021 - 2033 (USD Million)
  • Fig. 30 Hospital-owned centers, market, 2021 - 2033 (USD Million)
  • Fig. 31 Physician-owned centers, market, 2021 - 2033 (USD Million)
  • Fig. 32 Specialty pharmacy-owned centers, market, 2021 - 2033 (USD Million)
  • Fig. 33 Ambulatory infusion centers market: Age group segment dashboard
  • Fig. 34 Ambulatory infusion centers market: Age group market share analysis, 2025 & 2033
  • Fig. 35 Pediatric market, 2021 - 2033 (USD Million)
  • Fig. 36 Adults market, 2021 - 2033 (USD Million)
  • Fig. 37 Geriatric market, 2021 - 2033 (USD Million)
  • Fig. 38 Ambulatory infusion centers market revenue, by region, 2025 & 2033, (USD Million)
  • Fig. 39 Regional marketplace key takeaways
  • Fig. 40 Regional marketplace key takeaways
  • Fig. 41 North America ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 U.S. ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Canada ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Mexico ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 48 Europe ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Germany ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 UK ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 France ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Italy ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Spain ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Sweden ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Norway ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Denmark ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 65 Asia Pacific ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Japan ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 China ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 India ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Australia ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 South Korea ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 New Zealand ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 78 Latin America ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Brazil ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Argentina ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 83 Middle East & Africa ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 South Africa ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Saudi Arabia ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 UAE ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Kuwait ambulatory infusion centers market, 2021 - 2033 (USD Million)
  • Fig. 92 Company/competition categorization
  • Fig. 93 Company market position analysis, 2025
  • Fig. 94 Strategy mapping
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!